Trade Name | Drug Name | Approved | Patent Expires | Indication |
---|---|---|---|---|
Adenuric | Febuxostat | 2008-04-21 | 2024-2031 | |
Ciambra | Pemetrexed | 2015-12-02 | 2035 | |
Quofenix | Delafloxacin | 2019-12-16 | 2025-2033 | |
Ranexa (previously latixa) | Ranolazine | 2008-07-08 | 2038 | |
Spedra | Avanafil | 2013-06-21 | 2025 | |
Tenkasi (previously orbactiv) | Oritavancin | 2015-03-19 | 2029-2035 | |
Vaborem | Meropenem, Vaborbactam | 2018-11-20 | 2031-2039 | |
Ranexa | Ranolazine | 2006-01-27 | 2038 |
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
---|---|---|---|---|---|